Review article: the pathogenesis of fibrosis in non‐alcoholic steatohepatitis

Non‐alcoholic steatohepatitis has been recognized as a significant cause of end‐stage liver disease and hepatic decompensation. Despite the growing interest in this condition, the molecular mechanisms underlying the development of fibrosis in this setting are only partially understood. In this article, the cellular and molecular basis of fibrosis in chronic liver disease are briefly outlined. In addition, mechanisms specifically operating in the context of fatty liver and steatohepatitis are examined, including: insulin resistance, oxidative stress, and inflammation. Finally, recent developments indicating the possible contribution of cytokines derived from adipose tissue (adipokines) to liver fibrosis is discussed.

[1]  S. Kihara,et al.  Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. , 2003, Gastroenterology.

[2]  G. Robino,et al.  Oxidative stress-related molecules and liver fibrosis. , 2001, Journal of hepatology.

[3]  Z. Younossi,et al.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.

[4]  S. Dooley,et al.  Roles of TGF-beta in hepatic fibrosis. , 2002, Frontiers in bioscience : a journal and virtual library.

[5]  T. Roskams,et al.  Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research. , 2002, Journal of hepatology.

[6]  S. Milani,et al.  The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. , 2003, Gastroenterology.

[7]  H. Herbst,et al.  Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells. , 1997, Gastroenterology.

[8]  J. George,et al.  Fibrosis progression in chronic hepatitis C virus infection , 2004, Gut.

[9]  C. García-Monzón,et al.  Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. , 2000, Journal of hepatology.

[10]  V. Paradis,et al.  High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis , 2001, Hepatology.

[11]  M. Yuen,et al.  Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients , 2004, Hepatology.

[12]  P. Giral,et al.  Liver fibrosis in overweight patients. , 2000, Gastroenterology.

[13]  A. Gressner,et al.  Up‐regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts , 2001, Hepatology.

[14]  Y. Takei,et al.  Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals , 2001, Hepatology.

[15]  G. Marchesini,et al.  Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver , 2004, Hepatology.

[16]  S. Seki,et al.  In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. , 2002, Journal of hepatology.

[17]  I. Leclercq,et al.  CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. , 2000, The Journal of clinical investigation.

[18]  C. Day.  Pathogenesis of steatohepatitis. , 2002, Best practice & research. Clinical gastroenterology.

[19]  J. Dixon,et al.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. , 2001, Gastroenterology.

[20]  A. Gressner,et al.  Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. , 2004, Clinical chemistry.

[21]  F. Anania,et al.  Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  J. George,et al.  Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity? , 2002, Hepatology.

[23]  G. Marchesini,et al.  Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship? , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[24]  S. Friedman,et al.  Leptin in hepatic fibrosis: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice , 2002, Hepatology.

[25]  J. Clore,et al.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.

[26]  R. Hultcrantz,et al.  The Myofibroblastic Conversion of Peribiliary Fibrogenic Cells Distinct from Hepatic Stellate Cells Is Stimulated by Platelet-Derived Growth Factor During Liver Fibrogenesis , 2003, Laboratory Investigation.

[27]  Yu Wang,et al.  The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. , 2003, The Journal of clinical investigation.

[28]  K. Mak,et al.  Leptin Stimulates Tissue Inhibitor of Metalloproteinase-1 in Human Hepatic Stellate Cells , 2004, Journal of Biological Chemistry.

[29]  G. Bellomo,et al.  HNE interacts directly with JNK isoforms in human hepatic stellate cells. , 1998, The Journal of clinical investigation.

[30]  A. Tran,et al.  The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C. , 2003, Journal of viral hepatitis.

[31]  M. Serio,et al.  Signal Transduction by the Chemokine Receptor CXCR3 , 2001, The Journal of Biological Chemistry.

[32]  S. Friedman,et al.  Activation of hepatic stellate cells--a key issue in liver fibrosis. , 2002, Frontiers in bioscience : a journal and virtual library.

[33]  A. Lonardo,et al.  Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver , 2004, Hepatology.

[34]  M. Weltman,et al.  HFE mutations, hepatic iron, and fibrosis: Ethnic‐specific association of NASH with C282Y but not with fibrotic severity , 2002, Hepatology.

[35]  F. Folli,et al.  Insulin and insulin‐like growth factor‐1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: Differential effects on signal transduction pathways , 1999, Hepatology.